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ABSTRACT
This Integrative Review Project searched relevant literature and conducted research to discover
factors hindering HPV vaccination among children and young adults in America and
interventions to increase HPV vaccination among individuals in this group. The importance of
the HPV vaccination cannot be understated; the HPV vaccine is the most effective approach for
preventing infections and decreasing risk of HPV-associated conditions such as cervical, oral
pharyngeal, and rectal cancer.
In the United States, HPV inoculation uptake is reported to be less than 80% for the initial
dosage, and less than 40% of young males and females complete all the series dosage of the HPV
vaccination. The HPV vaccination has been approved since 2006, with many countries
undertaking measures and interventions to increase vaccination. HPV vaccination requires
multiple shots, offered in either two or three doses; the World Health Organization (WHO)
recommends an 80% uptake. The purpose of the project was to searched current literature to find
out why HPV vaccination is lower in the United States in comparison to other high-income
countries. The search included multiple databases: CINAHL, a conceptual framework that
supports methodological rigor, PRISMA data chronology flow chart is used for the processing of
the data review. The results show that increasing healthcare providers’ awareness, public
education, health literacy awareness, and partnership within the healthcare system can improve
HPV vaccination delivery. The project suggests that community awareness that the HPV vaccine
is safe and crucial in preventing HPV infection can significantly increase HPV vaccination
uptake in the United States.
Keywords: HPV infection, HPV vaccine uptake, HPV vaccine series completion, health
literacy or health education, challenges/difficulties in HPV vaccination.
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Section One: Formulating the Review Question
The number of people infected with the human papillomavirus has been approximated at
600 million globally, with a high-risk adolescent rate, which increases as with age (CDC, 2020).
Scientific societies, health organizations, and research evidence have, over the years,
recommended HPV vaccination for both girls and boys, indicating it as the most effective
approach toward preventing infections and decreasing the risk of associated cancers such as
cervical cancer. The HPV vaccination prevents six HPV-related cancers, including oral, rectal,
head, neck, throat, and cervical cancers. These cancers are caused by HPV types 6, 11, 16, and
18, which are responsible for 99% of cervical cancer and 90% of anogenital warts (CDC, 2020).
Presently, 53.7% of females and 48% of males between the ages of 13 and 17 are
vaccinated, and this is below the recommended guidelines for healthy people by the United
States Center for Disease Control and Prevention (CDC, 2020).
HPV vaccination is approved for usage in girls, boys, and young adults in many
countries, and there are measures and interventions to increase HPV vaccination rates. The HPV
vaccination requires multiple shots offered in two or three doses; the World Health Organization
(WHO) recommends an 80% uptake in HPV vaccination (WHO, 2017). Awareness campaigns
continue to increase the understanding that vaccination against HPV is safe and crucial in
preventing infection and associated cancers such as cervical cancers (WHO, 2018). During the
first decade of HPV vaccination initiatives within the United States, healthcare workers have
faced community, police, implementation, and monitoring challenges (Halista et al., 2020).
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Problem Statement
The United States HPV vaccination uptake data report is less than 80% for the initial
dosage and less than 40% for the series completion (WHO, 2017). In comparison, the United
Kingdom continues to have an uptake of about 88% for both doses among the female population,
with school nurses illustrated as the critical success factor in delivering the vaccine and ensuring
its promotion by creating awareness. Ralph et al. (2015) report that less-developed countries
have significantly lower uptake rates, but this is mainly related to the coverage of the HPV
vaccination. The uptake of the HPV vaccination is lower in the United States than in other
comparably high-income countries, and an enhanced effort has increased coverage levels in the
United States (Britt et al., 2015). These efforts considered increasing clinician awareness, public
education awareness, and partnership within the health system to improve HPV vaccination
delivery.
Purpose of the Project
Evidence indicates that various factors hinder HPV vaccination uptake, with parents
reported as the primary considerations, as they must give consent and approval for their children
to be vaccinated (Dilley et al., 2017). However, parents often lack awareness of the HPV
infection and vaccine, resulting in their disapproval of the vaccine (Monrose et al., 2017).
Further, WHO (2018) studies indicate that parents' attitudes towards the link between the HPV
vaccine, sexual behavior, and their health care professionals' recommendations may hinder their
consent for their children to be vaccinated. In contrast, studies have cited a lack of financial
resources as the primary factor for low vaccine uptake (Aragones et al., 2016). While parents are
the primary decision-makers regarding HPV vaccination uptake, Warner et al. (2017) argue that
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healthcare providers positively influence parents, and a recommendation from the provider can
result in the parent approving the HPV vaccine for their children.
Gender and sexual orientation also affect vaccination rates, with most parents and
healthcare professionals showing a preference for girls’ vaccination over boys’ (Zimmerman et
al., 2017). Finally, some studies focused on HPV vaccination dosage completion, citing distrust
and fear of the HPV vaccine and lack of financial resources. The HPV vaccination is also linked
to sexual behavior as the significant issue resulting in incomplete HPV vaccine dosage. While
many studies focus on HPV vaccine uptake, the current study aims to review and integrate
existing evidence and determine the significant barriers hindering HPV vaccination (Bautisca,
2016).
Defining Concepts and Variables
The main concepts and variables for this integrative review study include the Human
Papillomavirus (HPV) infection, Cervical Cancer, HPV vaccine, young adults, children,
prevention, and immunization with the man variables defined below:
1. HPV infection is transmitted sexually, affecting both genders (CDC, 2020).
2. Cervical cancer is a major cause of death globally, with about 300,000 deaths and
600,000 infections in 2018 (WHO, 2018).
3. The HPV vaccine is arguably the most effective prevention method for HPV infection,
focused on avoiding persistent infections, which can progress to invasive carcinoma
(Monrose et al., 2018).
The Rationale for Conducting the Review
In addition to school nurses, parental consent is another success factor for HPV
vaccination uptake. According to Beavis (2016), parental consent may be necessary, and
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healthcare providers need to understand parents' attitudes toward their children's vaccination.
Monrose et al. (2018) reported that parents consider the HPV vaccine as similar to any other
routine adolescent vaccine with positive attitudes reported to preventing cancer. Similarly,
Beavis (2016) identified positive attitudes towards the HPV vaccine, arguing that positive
attitudes are associated with increased HPV vaccination uptake. It is crucial to understand the
factors hindering healthcare providers from helping provide interventions that can increase U.S.
HPV vaccine uptake.
Calo et al. (2019) and Aragones et al. (2016) argued that public insurance also affected
vaccine uptake, indicating that public insurance was associated with lower initiation and
completion of the vaccine dosage in the United States. Racial and ethnic background, level of
education, and poverty levels influence why parents decide against HPV vaccine approval and
consent (Ralph et al., 2015). This research study is intended to present useful information about
factors influencing vaccine uptake and dosage completion. Understanding the barriers to HPV
vaccine uptake is crucial for securing vaccine delivery and ensuring that the efforts to optimize
the United States’ uptake are practical. An integrative review was initiated to assess existing
evidence on factors hindering HPV vaccination in the USA.
Research Question
The HPV vaccination was approved years ago, but its uptake is still not optimal despite
its positive impact, which includes the prevention of diseases such as cervical cancer (Britts et
al., 2015). There is growing improvement in the efficacy and dispensing of the HPV vaccine in
many developed economies, but the United States’ uptake rates are still low (WHO, 2017). There
is a need to acquire up-to-date evidence on the factors hindering HPV vaccine uptake in the
USA. The following questions guide the integrative review:
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1. What is the effect of health literacy on HPV vaccination uptake among children and
young adults?
2. What issues impact the expansion of HPV vaccination in individuals between nine
and 26 years of age?
Formulate Inclusion and Exclusion Criteria of the Literature
The inclusion and exclusion criteria provided an overview of the papers to be retrieved
and included for the integrative review. According to Toronto and Remington (2020), inclusion
criteria guide the researcher’s search for relevant articles based on diverse methodologies. The
inclusion criteria limited the studies to primary research published in the English language
between 2015 to date. The papers were excluded if they did not include the factors that affect the
HPV vaccination uptake in the USA. Attitudes, behaviors, and perceptions are defined because
of factors given for the failure to take the HPV vaccination or failure to complete the
recommended dosage. Duplicates were excluded as well as studies focusing on interventions for
HPV vaccine implementation.
Section Two: Comprehensive and Systematic Search Organization Reporting Strategies
The focus for the literature review was acquiring appropriate studies to review and
synthesize, enabling the study to acquire evidence on a research problem (Moran et al., 2017).
During the search process, errors and mistakes can occur, resulting in missed and inappropriate
identification of articles (Toronto & Remington, 2020). In presenting research studies,
appropriate search organization reporting strategies need to be adopted. This study employs the
Cochrane Database of Systematic Reviews by considering various items described below,
focused on ensuring appropriate articles are identified and reported.
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Synthesis
First, the search database framework was identified and evaluated using multiple
databases, including CINAHL, MEDLINE, Psych INFO, and Education Research. Liberty
University librarian assistance was consulted, and compliance with the information database
guideline was followed. The use of multiple databases increases the probability of acquiring
appropriate data to include in the study. Also, there is a need to point out the date range the
research covers to communicate to users that the review is up-to-date and refers to a particular
period as recommended by Toronto and Remington (2020). The integrative review clearly
illustrated by the search covered the years from 2015 to 2021 Thirdly, the search's date was
illustrated precisely when the review was undertaken, allowing for accountability (Torraco,
2016). According to Toracco (2016), there is a need to develop a search summary, and this
includes laying down the selection criteria and how it applies to selecting appropriate studies.
Toronto et al. (2018) identified the importance of stating language exclusion criteria and the
limitation of excluding relevant non-English articles.The current search strategy included only
English papers.
Conceptual Framework
The integrative review method involves the inclusion of both empirical and theoretical
publications. According to Toronto and Remington (2020), an integrative review is appropriate
in reviewing existing evidence, as it allows for the use of studies with diverse methodologies and
participants. Further, Toronto and Remington’s (2020) step-by-step guide is based on Cooper's
(2005) original integrative review framework and provides additional insights on conducting an
integrative review. The integrative review method allows for combining diverse methodologies
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and improved evidence-based experimental research and non-experimental research (Whittemore
& Knafl, 2005).
Terminology
Terms were identified to investigate and understand the barriers facing HPV vaccination
uptake in the USA among children and young adults. These included terminology on the
research problem and scope such as:
1. HPV vaccination
2. HPV vaccine
3. HPV infection
4. HPV vaccine uptake
5. HPV vaccine dosage completion
6. HPV vaccine series completion
7. Vaccines or vaccinations or immunizations
8. Health literacy or health education or health knowledge
9. Barriers or obstacles or challenges or difficulties or issues or problems
10. Demographic groups, social groups, economic groups
In the context of the study, health literacy represents the degree to which an individual can
understand health information and be able to apply the information to making lifestyle changes
that influence their health outcome (Britt et al., 2015). Vaccine uptake refers to the degree to
which people are willing to take the vaccination and complete the recommended doses. HPV
vaccination involves the vaccine given for preventing cervical cancers and other cancers, while
HPV infection refers to the sexually transmitted infection through sexual intercourse. The study
searched for these terms to review and identify the relevant research in the integrative review.
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Section Three: Methodology
The methodology for the integrative review included a conceptual framework devised by
Whittemore and Knafl (2005). The processes suggested by researchers was implemented to
maintain rigor and decrease bias and inaccuracy. The Liberty University librarian was also
consulted for search terms, databases, and research guides.
Synthesis reviews are present-knowledge capacity based on the existing body of scholarly
work because evaluation transcends existing knowledge's strengths and weaknesses and seeks to
create a more informative understanding (Toronto & Remington, 2020). The literature review
and integrative evaluation process considered the barriers to HPV vaccination among children
and young adults, seeking the discrepancies in HPV uptake and the effect of health literacy on
HPV vaccination rates. The integrative review aims to evaluate past and present research on
what intervention is available and the research challenges that require mitigation to increase
HPV vaccination among children and young adults from nine to 26 years of age.
A detailed framework supports methodological rigor, and the Preferred Reporting Items
underpinned the framework for the scholarly project for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines for critiquing articles (Toronto & Remington, 2020).
PRISMA Statement
PRISMA aims to support the reporting of an array of articles based on systematic reviews
to assess the benefits, strengths, and weaknesses of the research; the process includes screening,
selecting, and sorting of articles, and the PRISMA data chronology flow chart is used for the
processing of the data review (Toronto & Remington, 2020). The 27-item checklist and fourphase flow diagram map out the number of records identified in the review, those included and
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excluded, and reasons for exclusion (see Appendix A for PRISMA flow diagram) (Moher et al.,
2015).
The search focused on CINAHL, MEDLINE, Psych INFO, and Education Research,
using the following search string: HPV OR Human Papillomavirus AND vaccine OR vaccination
AND Barriers OR Factors OR Decision Making. The search focused on research articles
published between 2015 and 2020. All the articles identified in the abstract and title are searched
and reviewed; the researcher retrieved potential full texts for further review of articles to
determine that they were relevant for the study. Backward snowballing was used to identify
additional studies as recommended by Torraco (2016). The only studies included were those
reporting data collected in 2015 or later, addressing factors, barriers, and decision-making
involving HPV vaccination among young adults and children in the USA.
Each of the relevant articles were coded based on the target populations, topics such as
completion barriers, as addressed in the articles. The project leader read through the identified
full-text articles to ensure that they were relevant and met the inclusion/exclusion criteria set for
the study. The researcher synthesized findings based on the major themes and target population
of the paper's focus. Toronto and Remington (2020) hold the integrative review as the most
appropriate in drawing major aspects of existing studies and synthesizing them into a report.
After the synthesis, each section was reviewed to ensure accuracy in reporting. Any
discrepancies were reviewed and corrected based on the included articles for the review.
Ethical considerations are critical in a research process and guide the study as
information is gathered, analyzed, and reported (Torraco, 2016). In conducting integrative
reviews, ethical considerations are important, as they are frequently used and referenced in
documents that infer policy, research, and practice. In conducting the review, the study put into
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consideration several ethical issues and principles. First, the study considered the quality and
relevance of the included studies' evidence to ensure they aligned with the review purpose
(Torracco, 2016). In evaluating the quality and relevance of evidence, the study applied
evaluation criteria that involved a consideration of the validity of the findings and the level of
evidence using Melnyk's level of evidence as recommended by Melnyk Fineout-Overholt (2015).
Methods Appraisal Tool
The study observed reflectivity whereby the research considered the various publication
and search biases and their influence on the findings. Further, as recommended by Toronto and
Remington (2020), the project leader remained reflective of how their subjective positioning
impacted the review findings. Additionally, honesty and transparency were observed in the
review process, whereby the study provided a detailed description of the methodology used in
acquiring, synthesizing, and reporting the data.
The integrative research is geared toward understanding the barriers to HPV vaccination
documented in the literature and developing interventions that target those barriers and
discrepancies in various demographic areas and globally. Interventions providing health literacy
and awareness levels for parents are very significant because of the direct correlation with the
relevance of HPV vaccination in preventing six different types of cancer and reducing adverse
health outcomes throughout a lifetime.
Section Four: Quality Appraisal
Sources of Bias
While the integrative review provides insights into the barriers hindering HPV vaccine
uptake in the USA, various biased sources need to be considered. Toronto and Remington (2020)
hold that an integrative review helps manage bias, as it enables the inclusion of studies using
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diverse methodologies. First, most of the studies focused on the female, with males being highly
underrepresented. Thus, the barriers identified could be biased because there is limited inclusion
of males.
Validity
The study's validity is a critical element in scientific research (Torraco, 2016). A major
threat to validity identified in the study was the broad operationalization of terms limited to HPV
vaccination uptake barriers. As illustrated by Apaydin (2018), it is crucial to ensure the broadest
conceptualization is used and to critique each study before including it in the final project.
Second, there was the threat of inadequate sampling of included studies. While not all the
relevant studies can be included, there is a need to ensure the studies included are relevant for the
integrative review (Toronto & Remington, 2020). Finally, as recommended by Toracco (2016), it
is important to make sure that the included studies' samples reflect that of the targeted
population. The study accomplished this by ensuring that the sample population of the included
studies involved children or young adults in the USA.
Appraisal Tools
The Critical Appraisal Tool was employed to determine which articles to include and
exclude, to acquire further information from the authors to determine the most appropriate tool to
minimize research bias, the relevance of each research article to the topic, the research question,
and the quality of the paper. Recommended levels of evidence were designated based on the
methodology and approach utilized in the studies (Melnyk & Fineout-Overholt 2015). The
researcher evaluated empirical and non-empirical articles on a scale using high and low points
based on data relevance to the research topic and methodological data rigor of the study; thus,
the use of the PRISMA guidelines is recommended (Toronto & Remington, 2020).
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Applicability of Results
The integrative review focused on determining the barriers facing HPV vaccine uptake
among children and young adults in the USA. The findings are critical, as the evidence will
enable the development of interventions and frameworks to increase the HPV vaccine uptake. As
indicated by Bruni et al. (2016), despite strategies to improve HPV vaccination in the USA, the
country is trailing in HPV vaccine uptake compared to other developed countries such as the
United Kingdom and understanding the barriers to HPV uptake is essential to provide necessary
interventions.
Reporting Guidelines
The study reported the findings based on Melnyk & Fineout-Overholt’s (2015) level of
the evidence hierarchy. According to Toronto and Remington (2020), reporting guidelines are
crucial in enhancing a systematic research approach. The application of Melnyk's level of
evidence serve as a reporting guide for an accurate representation of the data (Melnyk &
Fineout-Overholt, 2015). The framework was adopted in the evidence levels and in developing
the synthesis for the study results.
Section Five: Data Analysis and Synthesis
Data Analysis Methods
The data was extracted using an Excel spreadsheet with headings to organize different
studies relevant to the integrative review. The main headings utilized included the authors, article
title and year of study, study purpose, sample characteristic, method, study result, level of
evidence, limitations of the study, and relevance of the evidence supporting a change. The
researcher summarized articles and, the reliability of the evidence included was evaluated using
the criteria set by the evidence-based (Melnyk Framework) level with each study's level of
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evidence identified (Melnyk & Fineout-Overholt, 2015). Toronto and Remington (2020)
recommend using thematic analysis in identifying major themes from the included study.
The patterns are grouped under theme names with the themes reviewed to ensure
appropriate representation of the data collected.
Descriptive Results
The researcher started the integrative review in November 2020 with 1,244 articles; 1,009
were identified as duplicates through a hand search. A duplicate involves a paper simultaneously
recorded in two or more databases. After the hand search, 235 articles remained for further
review. The study excluded articles whose research designs did not focus on specific barriers to
HPV vaccination in the United States, with 195 articles excluded. Ninety articles were retained
for the next stage, which involves excluding papers that did not provide full texts. Twenty-five
primary studies remained.
Synthesis
The 25 studies included in the integrative review answered the research question. Five major
categories of barriers against HPV vaccination in the USA were identified: parents, healthcare
professionals, gender and sexual orientation, disadvantaged communities, and barriers specific to
completing the HPV vaccine dosage, as synthesized below.
Parents
The findings identified parents as a major issue in HPV vaccination, as they must give
consent and approval (Cruz et al., 2017; Btoush et al., 2019; Overcoming barriers to HPV
vaccination, 2019). Various challenges and barriers hinder parents from giving their approval for
the vaccination. These include lack of understanding and knowledge of vaccines, lack of
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physician recommendation, attitudes towards HPV vaccine and sexual behavior, and financial
constraints, including a lack of insurance coverage (Berenson et al., 2019).
Lack of Knowledge
Parents' lack of awareness and knowledge is key to lower HPV vaccination in the United
States with ethnic minorities, immigrants, low levels of education, and low income linked to lack
of consent (Cruz et al., 2017). This aligns with past evidence, which holds that parents are
directly involved in HPV vaccination, and thus their knowledge and awareness is an important
dimension to consider (Inglehart et al., 2016; Glen et al., 2017). For instance, one of the studies
reported that Latina mothers' lack of knowledge in the USA hindered vaccine consent and
approval (Btoush et al., 2019). This is consistent with existing evidence, which holds that
parental involvement is key in HPV vaccine uptake, whereby parents can refuse their children's
vaccination as parental consent is required. However, studies demonstrated that despite Latina
mothers having a low understanding and knowledge about the HPV vaccination and infection,
they accepted and illustrated positive attitudes towards HPV vaccination (Glenn et al., 2015;
Aragones et al., 2016). Btoush et al. (2019) hold that the high cost of vaccines and fear of side
effects hindered parental approval for the vaccine.
Lack of Physician's Recommendations for the HPV Vaccine
The review also revealed that lack of provider recommendations acted as a barrier to
vaccination with the limited understanding of the HPV vaccine necessitating the approval by
health providers for the parents to be comfortable with their children being vaccinated (Aragones
et al., 2016; Albright et al., 2017; Cruz et al., 2017). While the above studies provide insights
into how Latina mothers' attitudes and knowledge in the US affect HPV vaccination uptake,
these studies do not consider the potential differences across diverse backgrounds. However,
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other studies have indicated that lack of recommendation and negative medical professional
perceptions negatively impact HPV uptake (Apaydin et al., 2018). The recommendations from
healthcare providers are thus a critical point of consideration for parents to enhance engagement
in increasing HPV vaccine uptake.
Parental Attitudes towards Increased Sexual Activity
The findings indicate fears that parents share associated with the link between the HPV
vaccine and sexual behavior (Bednarczyk et al., 2017; Cruz et al., 2017). These are contrasting
findings whereby the parental perception of a child's sexual activity is positively linked to HPV
vaccination while on the other hand, some parents perceive that vaccinating their children
equates with approval to engage in sexual activity (Btoush et al., 2019). Some studies revealed
that health care professionals used a risk-based approach based on the patient's perceived sexual
activity with the preference for older over younger patients and girls over boys to be vaccinated
(Daniel et al., 2016). This illustrates and suggests relationships between the HPV vaccination and
the child's sexual activity and the role of parents and health care professionals' perceptions over
sexual activity.
Cost of Vaccine and Insurance
The findings indicate lack of insurance covering HPV vaccination; the additional cost of
the HPV vaccine negatively impacted HPV uptake in the USA (Dilley et al., 2017; Aragones et
al., 2016; Albright et al., 2017; Calo et al., 2019). The findings demonstrate that vaccines' high
cost impacted parents’ consent with poverty levels and lack of insurance coverage negatively
impacting HPV vaccine uptake (Zimmerman, 2017). Further, the review stated women are more
likely to approve HPV vaccination than men (Bednarczyk et al., 2017). The low completion rates
for the HPV vaccine were due to a lack of finances to cover the vaccine (Albright et al., 2017).

HUMAN PAPILLOMAVIRUS (HPV) VACCINATION UPTAKE

21

Past evidence links poverty levels with low HPV vaccinations aligning with existing findings
from the integrative review (Bruni et al., 2016; Henry, 2017).
The findings imply while parents may accept the HPV vaccination, it may not increase the
HPV uptake among lower-income parents as they have no insurance coverage and financial
resources to ensure vaccination for their children.
Health Care Professionals
Some of the studies specifically focused on healthcare professionals and how they
hindered HPV vaccination. Two of the studies revealed a continued knowledge gap among
healthcare professionals on HPV vaccination (Beavis et al., 2016; Apaydin et al., 2018). For
instance, Bautisca et al. (2016) investigated the challenges facing public health and school nurses
in HPV vaccination. They revealed insufficient knowledge of the link between HPV infection
and conditions such as genital warts and non-cervical cancers; thus, they could not provide
adequate information to their patients on the relevance of the HPV vaccine. Some of the studies
indicated healthcare professionals offered little if any information and at times, too much
information, treating it as an optional vaccination in pharmacy-related HPV vaccination (Best et
al., 2018; Calo et al., 2019).
Further, some of the studies revealed the application of a risk-based approach whereby
the level of probability of a patient's sexual activity as preferences for receiving vaccine. Also
there is a preference for vaccinating older patients over younger patients, and vaccinating girls
over boys (Cruz et al., 2017; Daniel et al., 2016). Three of the studies identified financial
concerns whereby the healthcare professionals considered the availability of insurance for their
patients and the parents' economic status in making recommendations for HPV vaccinations
(Henry et al., 2018; Calo et al., 2019; Btoush et al., 2019). Healthcare professionals are critical in
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advancing HPV vaccination uptake, and healthcare professionals must have a continuous and
consistent understanding of their impact in promoting uptake. As illustrated in the analysis
above, healthcare professionals favor recommending HPV vaccinations for females, thus failing
to advise males to get the HPV vaccination.
Disadvantaged Communities
Nine of the studies focused on historically disadvantaged communities, addressing
specific barriers facing them. Variances in HPV acceptance, series completion, and knowledge
have been established across the minority groups with the barriers similar across minority groups
in the USA (Aragones et al., 2016; Glenn et al., 2015; Cruz et al., 2017; Btoush et al., 2019).
Knowledge of HPV-related issues is minimal among disadvantaged communities characterized
as having high poverty levels and low level of education (Cruz et al., 2017; Henry et al., 2017;
Btoush et al., 2019). Further, the lack of resources for the vaccine, its potential side effects, and
physicians' lack of recommendations impacted HPV vaccine uptake. This illustrates the
significant role healthcare professionals have on the HPV vaccination uptake. Evidence is
contrasting about the role of gender within disadvantaged communities. For instance, Btoush et
al. (2019) concluded mothers were hesitant to allow their adolescent girls to take the vaccine as it
may indicate approval to engage in sexual activity.
On the other hand, some healthcare professionals recommended the HPV vaccine when
there was a perception the child or young adult is about to commence sexual activity (Apaydin et
al., 2018; Henry et al., 2017; Berenson et al., 2019). Finally, disadvantaged communities
generally mistrusted the healthcare system, hindering them from receiving the HPV vaccine
(Henry et al., 2017; Aragones et al., 2016). The USA's disadvantaged communities face several
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barriers to accessing health care, which can be seen from the barriers faced in HPV vaccine
uptake.
Gender and Sexual Orientation
Evidence from the included studies indicated that an individual's gender and sexual
orientation played a part in whether they got the HPV vaccination with a preference towards
vaccinating girls over boys reported (Zimmerman et al., 2017; Daniel-Ulloa et al., 2016; Apaydin
et al., 2018). Additionally, Bednarczyk et al. (2015) argued men identifying as homosexual held a
mistrust for the health care system and feared stigma associated with sexual preferences that
hinder their HPV vaccination uptake. In contrast, in explaining the role of gender, Bednarczyk et
al. (2017) argued that it was not gender but the gender identity that the individual aligns with by
focusing on the HPV vaccination uptake among LGBT young adults in a rural area. However, the
study complements the findings of Apaydin et al. (2018) which concluded that the physicians
and healthcare professionals' attitudes and perceptions of the gender identity of the individual
impacted whether they recommended the HPV vaccine. Similarly, Btoush et al. (2019) and
DiClemente et al. (2015) concluded healthcare professionals illustrated preference in the
vaccination of girls over boys. Calo et al. (2019) stated parents relied on healthcare professionals
to provide information on the vaccine, and thus their biases and preferences were for vaccinating
young girls and not boys, a barrier for the vaccine uptake among young boys (Daniel-Ulloa et al.,
2015; Apaydin et al., 2018). Additionally, decision-making fathers were less likely to allow their
children to receive the vaccine (Bednarczyk et al., 2017). When participants were faced with
financial constraints, one of the studies stated girls were preferred over boys in getting the HPV
vaccine, given the impacts of the HPV infection were more widely known in girls than boys
(Daniel-Ulloa et al., 2016). Gender and sexual orientation therefore served as a barrier for HPV
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uptake, with existing evidence indicating limited research focus for the link between HPV
vaccination and gender as well as sexual orientation.
Section Six: Discussion
Implications for Practice/Future Work
HPV vaccine uptake is linked with the approval and consent of the parents who
understand the HPV infection and vaccine, recommendations from physicians, parental attitudes
towards sexual behavior, and insurance coverage or resources to cover the HPV vaccine cost
(Cruz et al., 2017; Dilley et al., 2017; Berenson et al., 2019). Several studies revealed that
parents were hesitant to expose their children to HPV vaccination due to concerns of safety, side
effects, and a general lack of understanding or awareness of the HPV vaccine (Cruz et al., 2017;
Btoush et al., 2019). Past evidence complements these findings, arguing that parents' lack of
awareness is linked to reduced approval and consent rates, thus impacting HPV vaccine uptake
(Albright et al., 2017). Implications for these findings include developing interventions geared
towards improving parents' knowledge and awareness of the significance and relevance of HPV
vaccination. Parents need to be aware that HPV vaccination prevents cancer and reduces the
likelihood of severe health outcomes.
Further evidence from the integrated review demonstrates that healthcare providers
critically influence the parental consent rates for the HPV vaccine, with results indicating that
healthcare providers are not fully prepared in their promotion of HPV vaccine as they lack
knowledge or give information which is confusing to parents (Cruz et al., 2017; Albright et al.,
2017). This adds to evidence that illustrates the significance of healthcare professionals in
increasing HPV vaccine uptake (Warner et al., 2017). Gynecologists, primary care providers, and
pediatricians should promote the HPV vaccine with targeted communication to vulnerable
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groups. The study's results explained that parental beliefs towards HPV vaccine and sexual
activity influence HPV vaccine consent and approval (Bednarczyk et al., 2017; Albright et al.,
2017). Fear of promoting sexual activity among their children was a barrier, and this may be
reinforced using a risk-based approach by a healthcare professional on perceived sexual activity
(Bednarczyk et al., 2017; Cruz et al., 2017; Apaydin et al., 2018).
The above findings complement the contention of WHO (2016), which states that most
vaccination programs target females However, the low percentage of males receiving the
vaccination is also due to the perceptions that HPV vaccination is for females (Henry et al.,
2017; Daniel-Ulloa et al., 2016). Attitudes and perceptions of parents that the HPV vaccination
increases promiscuity among young people are also factors of consideration in preventative
programs. It is essential to educate both parents and healthcare professionals on the risk of HPV
infection and the associated benefits of taking the HPV vaccination. The study’s findings imply
that the HPV vaccine's accessibility can increase HPV vaccine uptake where the vaccine is
subsidized or offered for free. The findings indicate that the barrier of costs and lack of insurance
is a significant challenge, particularly among the disadvantaged communities with a lack of
resources stated as the primary barrier (Aragones et al., 2016; Albright et al., 2017; Bruni et al.,
2016). It is aligned with evidence on the lack of funds to pay for the vaccine, which is cited as a
major challenge for parents, particularly those in disadvantaged communities (Scarinci et al.,
2020). Government support can increase HPV vaccination with interventions such as subsidies
or free vaccinations, particularly among communities with low-income levels. Calo et al. (2019)
and Zimmerman et al. (2017), also government interventions need to prioritize groups whose
high incidence rates for conditions have been associated with HPV infection, such as cervical
cancer.
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Healthcare professionals impact HPV uptake as they directly interact with parents,
including establishing parents’ trust in the recommendations they make (Warner et al., 2017;
Britts et al., 2015). Most of the included studies focused on pharmacists and school nurses, with
no studies focusing on physicians and their role in recommending the vaccine (Warner et al.,
2017). Parents acquire information when they take their children to healthcare centers, but their
perceptions, biases, and attitudes towards HPV vaccination can reduce or increase the HPV
vaccine uptake (Best et al., 2018; Beaves et al., 2016; Halista et al., 2020). Calo et al. (2019) and
Bautisca et al. (2016) hold that the use of a risk-based approach to HPV vaccine
recommendations, having little or no knowledge on the vaccine and provision of many details on
the vaccination, including possible risks and side effects acted as barriers to HPV vaccination.
This complements existing evidence that parents are highly influenced by their healthcare
providers and take cues on whether HPV vaccination is appropriate for their children or not
(Dilley et al., 2017). However, there is some past evidence that holds that as far as the parents
have knowledge and understanding of the HPV vaccination, physician recommendations,
whether limiting or promoting HPV vaccination, are less significant with parents who use their
knowledge and attitudes to impact their consent and approval (Best et al., 2018). The analysis
implies that increasing the understanding of healthcare providers on HPV infection and engaging
them in interventions is crucial in increasing HPV vaccination. For instance, healthcare
professionals should be educated on how vaccinating boys is as important as vaccinating girls.
Disadvantaged communities include immigrants and those with low education and high
poverty rates, with evidence indicating that the HPV vaccination uptake is low. The major
barriers identified include lack of funds for a vaccine, distrust for the vaccine and healthcare
system at large, and lack of knowledge and understanding of the vaccine (Calo et al., 2019;

HUMAN PAPILLOMAVIRUS (HPV) VACCINATION UPTAKE

27

Glenn et al., 2015; Aragones et al., 2016; Cruz et al., 2017; Henry et al., 2017; CDC, 2016, 2020;
DiClemente et al., 2015; Btoush et al., 2019; Halista et al., 2019; Ralph et al., 2015). Existing
evidence, however, holds that lack of funds and insurance are the major factors hindering uptake
within the disadvantaged communities and promotes lowering the cost of the vaccine as an
intervention to increase uptake (Aragones et al., 2016). Therefore, specific interventions focusing
on disadvantaged communities need to be developed and promoted, as evidence indicates very
low HPV vaccine uptake. This aligns with and complements past studies that hold that subsidies
on HPV vaccination among these disadvantaged communities would significantly improve their
HPV vaccine uptake (Btoush et al., 2019). Therefore, future studies should target disadvantaged
communities and investigate any interventions for increasing HPV vaccine uptake, including
programs to raise awareness.
The fourth central theme identified from the included studies is gender and sexual
orientation in boys' and girls' vaccination. The studies illustrated that perceived lack of benefits
or rationale for vaccinating results in lack of recommendations for HPV vaccine for both
genders, and the cost of the immunization hindered HPV vaccination (Monrose et al., 2017;
Beavis et al., 2016; Daniel-Ulloa et al., 2016; Albright et al., 2017; Bednarczyk et al., 2017;
Apaydin et al., 2018; Berenson et al., 2019). The findings support existing evidence that argues
that there is a preference towards HPV vaccination for young girls over boys, resulting in a lower
HPV vaccine uptake among boys (Glen et al., 2015). Further, in agreement with the conclusions
of Bednarczyk et al. (2017), in cases of LGBT and sexual orientation, healthcare professionals
are guided by the perceived gender identity of their clients in providing recommendations for the
HPV vaccine uptake (McRee, et al., 2018). The above findings illustrate that many healthcare
professionals and even parents have shown a tendency to vaccinate younger females, with little
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importance given to vaccinating boys. Such attitudes and perceptions hinder HPV vaccine uptake
with minimal vaccination among boys. There is a need for a more focused review of existing
evidence on gender and sexual orientation, and to conduct further studies on whether gender and
sexual orientation impact HPV vaccination uptake in the USA.
The studies revealed that the completion of the HPV vaccination was impeded by a low
perceived risk for HPV and fear of the vaccination's impacts, including encouraging sexual
activity, distrust of the healthcare system, and limited access to healthcare services. (Dilley et al.,
2017; Martinez-Lavin et al., 2017; Glenn et al., 2015; Britt et al., 2015b; Albright et al., 2017;
Berenson et al., 2019). However, Aragones et al. (2016) note that parental consent would be high
if the HPV vaccination was subsidized or offered for free, as the cost of the vaccine significantly
impacts the rate of vaccine uptake. This complements findings from past studies which note that
one of the significant issues and barriers facing HPV vaccination involves parents who either
disapprove of the HPV vaccine based on their perceptions such as linking it with sexual activity,
distrust the vaccine, and lack financial resources including insurance coverage to approve of the
vaccination (Best et al. 2018; Calo et al., 2019). This implies that more efforts need to target
patients who have already started the HPV uptake and ensure that awareness is successfully
created to complete the HPV vaccine dosage. As indicated by Berenson et al. (2019) and Scarinci
et al. (2020), for parents to follow through with the completion of the dosage, they need to not
only have access to the vaccine but also be aware of the importance of completing the dosage as
it increases the protection for their children against such conditions as genital warts and cervical
cancer. There is no major difference between the barriers to completion of HPV dosage and
starting on the dosage. However, there is a need for a more targeted study using an appropriate
sample to determine whether there is a significant difference between barriers for completing the
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dosage and starting the dosage. The research questions were answered in this integrative review
project, and the searched articles revealed that providing health literacy to health care providers
and parents increased HPV vaccine uptake; also, interventions that address vaccine costs, access
to care through vaccination programs increased HPV vaccination rates. Future studies need to
focus on understanding what intervention can successfully lead to the completion of HPV
dosage.
Dissemination
Dissemination is an essential aspect in the research process, as it allows the research
findings to be distributed by relevant parties such as policymakers and practitioners (Torraco,
2016). Several approaches will be applied to disseminating the research findings. First, the
research findings will be published in a peer-reviewed journal, which will expose the findings to
other researchers and policymakers. Further, the findings will be presented in conferences and
meetings of professional associations. Finally, the findings will also be shared on social media
platforms.
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Appendix A

March 5, 2021
Foluke Ajuwon
Cynthia Goodrich
Re: IRB Application - IRB-FY20-21-676 Factors hindering Human Papillomavirus (HPV) Vaccination among
children and young adult in America. An Integrative review
Dear Foluke Ajuwon and Cynthia Goodrich,
The Liberty University Institutional Review Board (IRB) has reviewed your application in accordance with
the Office for Human Research Protections (OHRP) and Food and Drug Administration (FDA) regulations
and finds your study does not classify as human subjects research. This means you may begin your
research with the data safeguarding methods mentioned in your IRB application.
Decision: No Human Subjects Research
Explanation: Your study is not considered human subjects research for the following reason:
(4) “Scholarly and journalistic activities (e.g., oral history, journalism, biography, literary criticism, legal
research, and historical scholarship), including the collection and use of information, that focus directly
on the specific individuals about whom the information is collected,” are not considered research
according to 45 CFR 46.102(l)(1).
Please note that this decision only applies to your current research application, and any modifications to
your protocol must be reported to the Liberty University IRB for verification of continued non-human
subjects research status. You may report these changes by completing a modification submission
through your Cayuse IRB account.
Also, although you are welcome to use our recruitment and consent templates, you are not required to
do so. If you choose to use our documents, please replace the word research with the word project
throughout both documents.
If you have any questions about this determination or need assistance in determining whether possible
modifications to your protocol would change your application's status, please email us at
irb@liberty.edu.
Sincerely,
G. Michele Baker, MA, CIP
Administrative Chair of Institutional Research
Research Ethics Office
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Many patients did not
Level 5
associate HPV infection with
their lifestyles , and the
relationship between HPV
and cancers.

Limited to one Does show
location(oncolog relationship
y practice)
between HPV
and cancers
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a mediation analysis indicate Level 4
that perceived behavioral
control completely mediates
the relationship between
eHEALS and HPV
vaccination intention.

Would Use as
Evidence to
Study
Support a
Limitations
Change? (Yes
or No) Provide
Rationale.
Limited to
Provides some
college students level of
only.
understanding
on education and
behavior change.

Britt, R. K., Collins, W. B.,
If eHealth literacy can increase
Wilson, K. M., Linnemeier, G., & the rate of HPV vaccination
Englebert, A. M. (2015). The role among college students.
of eHealth literacy and HPV
vaccination among young adults:
9 Implications from a planned
behavior approach.
Communication Research Reports,
32 (3), 208-215.
doi:10.1080/08824096.2015.10529
63

396 college
students using
the eHealth
literacy scale

Btoush et al. (2019). Toward
Human Papillomavirus
Vaccination Among Latina
Mothers of South American and
Caribbean Descent in the Eastern
10 US,

To examine knowledge,
attitudes, barriers, and
facilitators for human
papillomavirus (HPV)
vaccination among Latina
mothers of HPV vaccineeligible children in low-income
urban areas, as well as useful
strategies to improve HPV
vaccination.

132 Latina
Qualitative
mothers of HPV studies
vaccine-eligible
children

The study concluded that
lack of health care provider
recommendations, lack of
knowledge by mothers on
HPV infection and
vaccination were the major
barrier to HPV vaccination.

Level V

The study was
limited to lowincome Latina
mothers.

Yes

Calo et al. (2019). Implementing
pharmacy-located HPV
vaccination: findings from pilot
11 projects in five U.S. states.

to document challenges and
opportunities of implementing
pharmacy-located HPV
vaccination services in five US
states

pharmacylocated HPV
vaccination
services

Case study

The study reported that
insurance coverage, lack of
accessibility to health care
services, and low
engagement of parents with
the pharmacies.

Level 4

The study was
limited to
pharmacies
which were
providing HPV
vaccine.

Yes, It does
provide useful
information

Cruz et al. (2017). Human
papillomavirus (HPV) vaccination
motivators, barriers, and brochure
preferences among parents in
12 multicultural Hawai‘i: A
qualitative study.

To identify HPV vaccination
Parents of teens
barriers, motivators, and
brochure preferences among
parents of teens in multicultural
Hawai‘i.

Qualitative
review

The study reported that the
Level 5
physician recommendations,
the stigma of sexual behavior
after vaccination, awareness
on HPV related issues are the
major barriers to vaccination.

The study had a Yes, It does
small sample of provide useful
20 parents and
information
were all
mothers.

Daniel-Ulloa et al. (2016). Human
papillomavirus vaccination in the
United States: Uneven Uptake by
gender, race/ethnicity, and sexual
orientation.

CorrelationalDesign

Study Results

40

To assess national differences in
human papillomavirus (HPV)
vaccine uptake among young
adults in the United States by
gender, race/ethnicity, and
sexual orientation.

Respondents are Case study, coaged 18 to 30
hort.
years from the
2013 National
Health Interview
Survey.

The study reported that males Level 6
were underrepresented in
HPV vaccination uptake and
disadvantaged women had
lower rates of initiation and
completion of vaccine series
compared to White women.

The study
Yes, It does
focused on HPV provide useful
vaccination
information
uptake in the US
by race, gender
and sexual
orientation and
did not
acknowledge the
other barriers
faced.

Dilley, S. E., McGuire, A. A.,
Straughn, J. M., Leath, C. A., &
Scarinci, I. C. (2017). Quantitative
and qualitative evaluation of
14 pediatrician attitudes and barriers
to HPV vaccination. Gynecologic
Oncology, 145 , 156-157.
doi:10.1016/j.ygyno.2017.03.362

Evaluate insight from
pediatricians on the factors
affecting HPV vaccination
rates, as well as their strategies
for improving vaccine uptake

46 pediatricians Quantitative,
in the state.
Qualitative
evaluative.

Strategies to increasing HPV Level 3
vaccine uptake in
pediatrician offices is a
major priority

Low
participation
from
pediatricians in
low-economic
area

Glenn et al. (2015). Understanding
HPV vaccination among Latino
15 adolescent girls in three U.S.
regions.

To assess HPV vaccine
initiation and correlates of
initiation among Latina
adolescents.

caregivers of
Latina
adolescents

Case study

The study was
Yes, It does
limited to Latina provide useful
adolescents.
information

Halista, C. E., Kline, R. J., &
Bepko, J. (2020). Understanding
barriers to HPV vaccination:
Perspectives from air force family
16 medicine physicians and active
duty air force males. Military
Medicine, 185 (5-6), e878-e886.
doi:10.1093/milmed/usz403

Evaluate barriers to HPV
vaccination among males

49 family
medicine
Doctor.

Interviews,
statistics with
frequencies and
percentages. 3
months.

The study cited lack
Level 4
awareness, perceptions of its
influence on sexual behavior
and lack of understanding of
its potential effects.
Deficiencies in public
Level 4
knowledge and insufficient
provider practices are likely
contributing to the
suboptimal rates of HPV
vaccination among eligible
males

13

Provide good
foundation
information.

Limited to males Provide
ages 18-26 years information on
only.
rationale behind
low vaccination
rates in Males

HUMAN PAPILLOMAVIRUS (HPV) VACCINATION UPTAKE

#

`Article Title, Author, etc.
(Current APA Format)

Study Purpose

Sample
(Characteristics
of the Sample:
Demographics,
etc.)

Methods

Study Results

41

Level of
Evidence
(Use Melnyk
Framework)
Level 5

Study
Limitations

Henry et al. (2017). Area-based
socioeconomic factors and Human
Papillomavirus (HPV) vaccination
among teen boys in the United
17 States.

To examine associations
between several area-based
socioeconomic factors and
human papillomavirus (HPV)
vaccine uptake among boys in
the United States (U.S.).

boys aged 1317 years.

Qualitative
review

The study concluded that
poverty did not impact
initiations rates but affected
completion rates for HPV
vaccine uptake while boys
from disadvantaged
communities had low HPV
vaccine rates.

The study was
limited to boys
and thus cannot
provide
generalizations
for children and
young adults.

Inglehart, R. C., Taberna, M.,
Pickard, R. K. L., Hoff, M.,
Fakhry, C., Ozer, E., . . . Gillison,
M. L. (2016). HPV knowledge
gaps and information seeking by
18
oral cancer patients. Oral
Oncology, 63 , 23-29.
doi:10.1016/j.oraloncology.2016.1
0.021

Provide health education on
HPV infection in order to
enhance patients understanding
of HPV.

372 cancer
patients

Prospective,
survey,
interviews, cohurt study

Effective health literacy,
Level 4
defined as the ability to
access and effectively utilize
health information, is linked
with better health outcomes

One singles
location from
2011-2015

Would Use as
Evidence to
Support a
Change? (Yes
or No) Provide
Rationale.
Yes, It does
provide useful
information

Does provide
overview of
importance of
health literacy

Martínez-Lavín, M., & Amezcua- Evaluate individuals sideGuerra, L. (2017). Serious adverse effects to HPV vaccination
events after HPV vaccination: a
critical review of randomized trials
and post-marketing case series.
19
Clinical Rheumatology, 36(10),
2169–2178. https://doiorg.lopes.idm.oclc.org/10.1007/s10
067-017-3768-5

3088 individuals Randomized
ages 8-26 years control trial

Redness at site of injection
was reported, some adverse
events occurred which was
rule out as not vaccinerelated.

Level 2.

More research ne Yes. Does
provide
information for
clinical research
.

McRee, A.-L., Shoben, A. B., &
Reiter, P. L. (2018). 18 - Effects of
a Pilot Randomized Controlled
Trial of a Web-Based HPV
20 Vaccination Intervention for
Young Gay and Bisexual Men: the
Outsmart HPV Project. Journal of
Adolescent Health, 62, S10.

The purpose of the study is to
evaluate the effect of health
education-vaccination
intervention in high risk group

150 male
Randomized
individuals with control trial
high-risk
behavior.

HPV vaccine initiation at 7
Level 1
months was higher among
group who received Outsmart
HPV
compared to the control
group and indicated that
monthly vaccine reminder
were convenient.

Limited to male Yes, the study
individuals only show evidence
that intervention
can increase
vaccination rate.

Monrose, E., Ledergerber, J.,
Acheampong, D., & Jandorf, L.
(2017). Cancer screening
information at community health
fairs: What the participants do with
information they receive. Journal
21
of public health research , 6 (2),
866.
https://doi.org/10.4081/jphr.2017.8
66

the purpose the study was to
examine the effectiveness
dissemination HPV information
in local health fairs in order to
increase HPV vaccination
awareness among underserved
populations.

Local
community fair
in underserved
areas from June
to August.116
participants.

Mixed
HPV vaccination barriers
Level 4
quantitative and include lack of knowledge or
qualitative study. awareness of cancer
screenings, lack of access to
general preventive health
care services, institutional or
system barriers,
socioeconomic status,
language barriers, immigrant
status, and cultural beliefs

Some
Does provide
participants
information on
might give bias the underserved.
information.
Most participant
have no PCP.

Overcome Barriers to HPV
HPV rates among teen in
Vaccination. (2019).
different demographic areas, in
Contraceptive Technology Update, the Urban and rural area
40 (7)
http://ezproxy.liberty.edu/login?qur
22
l=https%3A%2F%2Fwww.proques
t.com%2Fdocview%2F223745590
4%3Faccountid%3D12085

19 states

Research based,
practice based
research network
with NIH and
America
Academy of
Pediatrics(AAP).

Patient group is Does provide
limited to those information
with PCP.
useful in
interventions to
increase HPV
rates.

DiClemente, R. J., Murray, C. C.,
Graham, T. & Still, J. (2015)
Overcoming barriers to HPV
vaccination: A randomized clinical
trial of a culturally-tailored, media
23 intervention among African
American girls, Human Vaccines
& Immunotherapeutics, 11:12,
2883-2894, DOI:
10.1080/21645515.2015.1070996

216 African
Randomization, Participants in the
Level 2.
American
controlled trials. intervention were more likely
adolescent
to complete their vaccination
females (ages
series, than those in the
14–18 years)
placebo group, who showed
seeking services
lower vaccination completion
in family
rates.
planning and
STI public
health clinic.

To show the effectiveness and
influence of the patient-provider
encounter in a clinical setting on
HPV vaccination rate.

Result shows the number of Level 3
rural teens who received the Controlled
first dose of the HPV vaccine study
lagged 11 percentage points
lower than the number in
urban areas.

More research
needed to
understand
factors that
increases
vaccination rate.

Yes, provides
good
information on
effectiveness of
health
education/interv
ention.
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there is significant HPV
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Level 2.

Would Use as
Evidence to
Study
Support a
Limitations
Change? (Yes
or No) Provide
Rationale.
Primary care
Yes. Information
provider myst
will be used to
have a broadenhanced
base presence in research.
diverse clinical
practive to
enhance the
grought of
vaccination
among
adolescence.

Scarinci, I. C., Hansen, B., & Kim,
Y. (2020). HPV vaccine uptake
among daughters of Latinx
immigrant mothers: Findings from
a cluster randomized controlled
trial of a community-based,
24 culturally relevant intervention.
Vaccine , 38(25), 4125–4134.
https://doiorg.lopes.idm.oclc.org/10.1016/j.v
accine.2020.03.052

To evaluate reasons for
increase in HPV vaccination
rates among certain
demographic(Latina
Immigrants)

Community
based setting

Warner, E. L., Ding, Q., Pappas,
L., Bodson, J., Fowler, B.,
Mooney, R., . . . Kepka, D. (2017).
Health care providers' knowledge
25 of HPV vaccination, barriers, and
strategies in a state with low HPV
vaccine receipt: Mixed-methods
study. JMIR Cancer, 3 (2), e12e12.

The associations between
demographic and practice
characteristics of the health care
providers with the knowledge of
HPV vaccination and HPV
vaccine guidelines.

254 participants Mixed study
from different
with chi-square
demographic
tests.
settings.

The providers' perceptions of Level 3
barriers to HPV vaccination
and strategies for improving
vaccination in a state with
low HPV vaccine

Done in one
state, not sure if
results can be
replicated in
other states.

Does provide
good
information on
providers
perspective on
barriers to HPV
vaccination.

10,861 adolescnt Randomized
population with control trial
Age range of 11 17 years old
patients of 50 or
more practice

HPV initiation increased
with intervention more than
primary care clinic.

At the time of
the study,
baseline data of
randomized
vacination was
not available

Provide good
foundation
information.

Zimmerman, R. K., Moehling, K. Improving HPV vaccination rate
K., Lin, C. J., Zhang, S., Raviotta, amont the adolescent.
J. M., Reis, E. C., Humiston, S. G.,
& Nowalk, M. P. (2017).
Improving adolescent HPV
vaccination in a randomized
26 controlled cluster trial using the 4
Pillars (TM) practice
Transformation Program. Vaccine,
35(1), 109–117. https://doiorg.lopes.idm.oclc.org/10.1016/j.v
accine.2016.11.018

Randomized
control trial

Study Results
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Level 2

